O le a le uiga o le “manino”?
E le tauaveina e le manu le suiga. O le a le tupu ai le ma'i ma o le a lē tuʻuina atu.
Cerebellar Degeneration-Myositis Complex (CDMC) is a genetic condition affecting dogs, leading to severe neurological and muscular issues. A DNA test for CDMC can help identify carriers and affected dogs, allowing for informed breeding decisions. Early detection through genetic testing is crucial, as it enables proactive management and care for affected pets. Owners should consult with veterinarians to understand the implications of a positive CDMC test result. By prioritizing genetic health, dog breeders can contribute to the overall wellness of future generations. Ensure your dog's health and well-being by considering a DNA test for CDMC today. Stay informed and take action to protect your furry friends from hereditary conditions.
Cerebellar Degeneration-Myositis Complex (CDMC) is a genetic condition affecting certain dog breeds, leading to neurological and muscular issues. A DNA test can identify carriers and affected individuals, helping breeders make informed decisions to reduce the prevalence of this complex disorder. Symptoms may include coordination problems and muscle weakness, which can significantly impact a dog's quality of life. Early detection through genetic testing allows for better management and care. Responsible breeding practices are essential in minimizing the risk of CDMC in future generations.
O lenei su'ega DNA e aofia ai e amata mai i le matou pusa Basic — ma o se vaega foi o pusa Basic, Standard, Advanced, Complete.
Va'ai DNA Su'ega Packs →Cerebellar Degeneration-Myositis Complex (CDMC) is a serious neurological and muscular condition that affects dogs. This complex disease is characterized by two main components: cerebellar degeneration, which impacts the brain's ability to coordinate movement, and myositis, an inflammatory condition of the muscles. Together, these issues can lead to a range of debilitating symptoms that impact a dog's quality of life.
Dogs suffering from CDMC often exhibit a variety of symptoms that may vary in severity. Common clinical signs include ataxia, which is a lack of coordination and balance, leading to difficulty in walking and performing routine activities. Affected dogs may also display tremors, muscle weakness, and a noticeable decline in muscle mass due to myositis. In some cases, the condition may cause behavioral changes, including lethargy or reluctance to engage in physical activities.
The pathophysiology of CDMC involves a combination of neurological and immunological factors. The cerebellum, responsible for coordination and balance, suffers from degeneration, while the immune system mistakenly targets muscle fibers, leading to inflammation. This dual impact results in the clinical signs observed in affected dogs. Research into the underlying genetic and environmental factors contributing to CDMC is ongoing, with a focus on understanding how these elements interact to trigger the disease.
DNA testing plays a crucial role in identifying and diagnosing CDMC in dogs. By analyzing specific genetic markers associated with the condition, veterinary professionals can determine the likelihood of a dog carrying the genes responsible for CDMC. Early detection through DNA testing can provide pet owners with valuable information regarding their dog's health and guide them in making informed decisions about management and care.
Currently, there is no cure for CDMC; however, various management strategies can help improve a dog's quality of life. Supportive care, including physical therapy and nutritional support, can play a significant role in maintaining muscle strength and mobility. In some cases, medications to reduce inflammation and manage symptoms may be prescribed. Regular veterinary check-ups are essential for monitoring the condition and adjusting treatment plans as needed.
Cerebellar Degeneration-Myositis Complex (CDMC) is a complex and challenging condition that requires careful management and support. Understanding the nature of this disease, its symptoms, and potential treatment options is critical for pet owners. DNA testing serves as a valuable tool in the early detection and management of CDMC, enabling better health outcomes for affected dogs.
E le tauaveina e le manu le suiga. O le a le tupu ai le ma'i ma o le a lē tuʻuina atu.
Leai. E masani ona soifua maloloina le manu ae e mafai ona tuʻuina atu le suiga i lona fanau.
E lua kopi suia. Fa'ailoga fa'afoma'i e fa'amoemoe e fa'atatau i le faama'i. E le tatau ona fafaga.
O nisi faʻamaʻi e fesoʻotaʻi feusuaʻiga, o lea e eseese ai o latou faʻaaliga e faʻatatau i le itupa a manu.
This DNA test detects the mutation associated with Cerebellar Degeneration-Myositis Complex (CDMC) in order to identify clear, carrier, or at-risk animals.
O le su'ega DNA e fesoasoani i le au faifa'ato'aga e fuafua ni faigauo saogalemu ma fa'aitiitia ai le lamatiaga o le tu'uina atu o le suiga i fanau.
Ole fa'asologa ole tofi na lipotia mo lenei su'ega ole Autosomal Recessive.
This test analyses the mutation SLC25A12 c.1337C>T.
E le faapea. O le fa'auigaina e fa'alagolago i le fa'asologa o tofi ma le fa'atupuina o le genotype.
Christen Matthias, Rupp Stefan, Van Soens Iris, Bhatti Sofie F M, Matiasek Kaspar, von Klopmann Thilo, Jagannathan Vidhya, Madden Indiana, Batcher Kevin, Bannasch Danika, Leeb Tosso. SLC25A12 Missense Variant in Nova Scotia Duck Tolling Retrievers Affected by Cerebellar Degeneration-Myositis Complex (CDMC). Genes (Basel). 2022 Jul 9;13(7):1223. doi: 10.3390/genes13071223.
O lau fa'alilolilo, lau filifiliga
Matou te fa'aogaina kuki taua e fa'atautaia ai le upega tafa'ilagi. O kuki e filifili ai (e pei o kamupani o lo'o fa'apipi'i) e fa'aletonu ona o le fa'aletonu ma e na'o le avanoa pe a e malie. E mafai ona e suia lau filifiliga i soʻo se taimi e faʻaaoga ai le ki "Kuki".
Manaomia mo vaega autu ma le saogalemu. E mafai i taimi uma.
Fa'aleleia foliga e pei o le fa'apolopolo o mea e mana'o i ai po'o mea e le fa'asalalauga.
Fesoasoani ia matou malamalama i le fa'aogaina o nofoaga. Ua le atoatoa ona o le faaletonu.
Fa'asalalauga/su'esu'e i luga ole laiga (o nisi ata vitio/fa'afanua fa'apipi'i). Ua le atoatoa ona o le faaletonu.